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Abstract
Background:  We sought to determine the frequency and distribution of cardiovascular
comorbidities in a large cohort of low-income patients with diabetes who had received primary
care for diabetes at municipal health clinics.
Methods: Outpatient data from the Philadelphia Health Care Centers was linked with hospital
discharge data from all Pennsylvania hospitals and death certificates.
Results: Among 10,095 primary care patients with diabetes, with a mean observation period of
4.6 years (2.8 after diabetes diagnosis), 2,693 (14.3%) were diagnosed with heart disease, including
270 (1.4%) with myocardial infarction and 912 (4.8%) with congestive heart failure.
Cerebrovascular disease was diagnosed in 588 patients (3.1%). Over 77% of diabetic patients were
diagnosed with hypertension. Incidence rates of new complications ranged from 0.6 per 100 person
years for myocardial infarction to 26.5 per 100 person years for hypertension. Non-Hispanic whites
had higher rates of myocardial infarction, and Hispanics and Asians had fewer comorbid conditions
than African Americans and non-Hispanic whites.
Conclusion:  Cardiovascular comorbidities were common both before and after diabetes
diagnosis in this low-income cohort, but not substantially different from mixed-income managed
care populations, perhaps as a consequence of access to primary care and pharmacy services.
Background
Patients with diabetes are at increased risk of a wide range
of complications and comorbidities, which adversely
affect quality of life, mortality, and health care services uti-
lization. Cardiovascular diseases are the primary causes of
morbidity and mortality among patients with diabetes,
yet data on cardiovascular disease among patients with
diabetes are limited [1]. Although microvascular patholo-
gies, including retinopathy and nephropathy, have been
shown to be strongly associated with glycemic control,
macrovascular complications, including heart disease and
cerebrovascular disease, appear to be less responsive to
glycemic control, and strategies to reduce them are
focussed on controlling other risk factors such as hyper-
tension, hyperlipidemia, smoking, and obesity [2]. This
complex array of risk factors and outcomes makes diabe-
tes care exceptionally demanding both for patients and for
health care providers.
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Data on the prevalence and incidence of macrovascular
comorbidities are largely derived either from clinical trials
with selected patient populations, self-reported cross-sec-
tional survey data, or managed-care studies of insured
patients of higher socioeconomic status. The rising preva-
lence of diabetes in low-income inner-city populations
underscores the need to understand the frequency with
which these comorbidities occur in such populations and
to assess possible disparities in their occurrence.
The Philadelphia Health Care Centers (HCCs) provide
primary care and pharmacy services to approximately
100,000 patients annually through eight neighborhood
centers and one sexually transmitted disease clinic. Indi-
vidual patients are not billed for any services provided.
Although the HCCs are available to all Philadelphia resi-
dents, their patients are almost universally low-income;
over 60% have no health insurance. A majority of HCC
patients are African American, but there are also substan-
tial numbers of non-Hispanic white, Hispanic, and Asian
patients. Diabetes is one of the most common diagnoses
among adult HCC patients. Since to our knowledge no
previous study has reported the prevalence or incidence of
cardiovascular diseases in a comparable, ethnically
diverse, low-income diabetic population, we sought to
determine the frequency and distribution of cardiovascu-
lar comorbidities among HCC patients with diabetes.
Methods
The Urban Diabetics Study cohort consists of 10,095
patients diagnosed with diabetes in the HCCs between
January 1, 1996 and December 31, 2001. All diabetic
patients were included except those for whom Social Secu-
rity numbers were unavailable (less than 6% of all dia-
betic patients). All HCC visits between March 1, 1993 and
December 31, 2001, all hospital discharges from any
Pennsylvania hospital between January 1, 1993 and
December 31, 2001, and death records have been linked
for these patients. The data includes outpatient visits and
hospitalizations both before and after the initial diabetes
diagnosis, within the study time period. Race/ethnicity
was classified based on the outpatient records. Diabetes
incidence was calculated based on the admission date of
the first hospitalization for which a diabetes diagnosis was
recorded or the date of the first HCC outpatient visit for
which a diabetes diagnosis was recorded, whichever came
first.
The cardiovascular comorbidities assessed included any
heart disease (ICD9 codes 402 and 410–429, ICD10
codes I5-I9, I11, I13, I20-I27, and I30-I52), myocardial
infarction (MI) (ICD9 code 410, ICD10 codes I21-I23),
congestive heart failure (CHF) (ICD9 code 428, ICD10
code I50), cerebrovascular disease (ICD9 codes 430–438,
ICD10 code I6), and hypertension (ICD9 codes 401–405,
ICD10 codes I10-I15). For each comorbid condition we
assessed baseline prevalence at or before first diabetes
diagnosis, incidence rate per 100 person-years of follow-
up time following first diabetes diagnosis among those
free of the condition at baseline, and cumulative preva-
lence, i.e., any occurrence over the course of the observa-
tion period. Logistic regression and proportional hazards
regression were used to simultaneously assess multiple
demographic risk factors, including sex, race/ethnicity,
exact age, and year of diabetes incidence. Patients with
unknown race/ethnicity (n = 7) were excluded from mul-
tivariable analyses.
Results
Demographic characteristics of the 10,095 patients
included are shown in Table 1. Mean age at diabetes diag-
nosis was 49.2 years, and mean observation period was
4.59 years, including 1.74 years before and 2.85 years after
first known diabetes diagnosis. Among the patients for
whom income was ascertained, median income was
$7,092; 86% had annual incomes below $15,000. Table 2
shows which of the linked data sources provided diag-
noses of each comorbidity.
Heart disease
Baseline prevalence of any heart disease was 14.8 %,
including 4.1% with CHF and 1.0% with MI (Table 3). In
multiple regression analyses, non-Hispanic white race/
ethnicity (compared to the African-American reference
group) was associated with substantially higher baseline
prevalence of MI (Table 4). Hispanic race/ethnicity was
associated with lower baseline prevalence of CHF, and
Asian race/ethnicity was associated with lower baseline
prevalences of MI, CHF, and any heart disease. Age and
male sex were positively associated with baseline preva-
lence of MI, CHF, and any heart disease. Year of diabetes
diagnosis was negatively associated with baseline preva-
lence of MI, CHF, and any heart disease, indicating that
baseline prevalences declined between 1996 and 2001.
Incidence of heart disease, among those who had not
been diagnosed with it at the time of their diabetes diag-
nosis, was 5.36 cases per 100 person-years, with 13.9% of
those at risk being diagnosed before the end of the study
period (Table 3). Incidence of MI was 0.59 per 100 per-
son-years. Incidence of CHF was 1.85 per 100 person-
years. In multiple regression analyses (Table 5), Non-His-
panic whites, as compared to African-Americans, were at
higher risk of MI and all heart disease. Hispanic and Asian
patients were at lower risk of CHF. Incidence of heart dis-
ease increased slightly with later year of diabetes diagno-
sis. Age at diabetes diagnosis was associated with higher
incidence of all heart disease outcomes, as was male sex.BMC Public Health 2005, 5:15 http://www.biomedcentral.com/1471-2458/5/15
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Through the entire study period, 2,693 patients (26.7%)
were diagnosed with heart disease (Table 3). MI was
diagnosed in 270 patients (2.7%) and CHF in 912 (9.0%).
In multiple regression analyses (Table 6), Non-Hispanic
white race/ethnicity was associated with higher cumula-
tive prevalence of MI (odds ratio [OR] 1.90) and any heart
disease (OR 1.32). Hispanic race/ethnicity was associated
with lower cumulative prevalence of CHF and any heart
disease (OR 0.78, 95% CI 0.66–0.91). Asian race/ethnic-
ity was associated with lower cumulative prevalences of
all heart disease outcomes. Age at baseline and male sex
were positively associated with cumulative prevalence of
MI, CHF, and any heart disease. Year of diabetes diagnosis






N N N N N N N
Total 10095 7243 1119 1056 394 276 7
Females 5671 4230 528 540 224 145 4
Age
0 – 4 1 7 1 2 22100
5–14 38 28 2 2 4 2 0
15–24 213 149 25 28 8 3 0
2 5 – 3 4 4 7 7 3 5 9 5 24 11 11 4 0
35–44 1086 826 89 97 50 23 1
45–54 1614 1214 161 151 50 35 3
55–64 1542 1139 142 146 72 41 2
6 5 – 7 4 5 0 8 3 6 2 4 45 52 12 5 1
75–84 149 114 11 16 6 2 0




1996 948 720 79 90 45 14 0
1997 969 714 78 116 40 20 1
1998 817 604 77 88 23 24 1
1999 854 637 92 74 26 25 0
2000 926 699 84 75 35 33 0
2001 1157 856 118 97 55 29 2
Males 4424 3013 591 516 170 131 3
Age
0 – 4 2 8 2 6 01100
5–14 78 68 7 2 1 0 0
15–24 419 371 20 22 3 3 0
25–34 1174 1015 81 55 15 7 1
35–44 2567 2243 155 113 29 26 1
45–54 3183 2797 163 132 52 38 1
55–64 2807 2467 119 134 45 42 0
6 5 – 7 4 9 0 2 8 0 0 3 63 22 01 4 0
75–84 290 254 9 23 3 1 0




1996 732 509 92 101 17 13 0
1997 743 496 96 101 27 22 1
1998 692 486 95 74 21 16 0
1999 638 423 80 84 24 27 0
2000 694 457 103 75 33 25 1
2001 925 642 125 81 48 28 1BMC Public Health 2005, 5:15 http://www.biomedcentral.com/1471-2458/5/15
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was negatively associated with cumulative prevalence of
each of the heart disease outcomes.
Cerebrovascular disease
Cerebrovascular disease was diagnosed in 588 patients,
evenly split between cases diagnosed at baseline and inci-
dent cases subsequent to diabetes incidence (Table 3).
Baseline prevalence of cerebrovascular disease was 2.9%.
In multiple regression analyses (Table 4), Hispanic, Asian,
and "other" race/ethnicities were associated with lower
baseline prevalences of cerebrovascular disease. Age at
baseline and male sex were positively associated with
baseline prevalence of cerebrovascular disease, while year
of diabetes diagnosis was negatively associated with base-
line prevalence of cerebrovascular disease (OR 0.78, 95%
CI 0.74–0.83).
The incidence rate for cerebrovascular disease, among
those free of it at baseline diabetes diagnosis, was 1.07 per
100 person-years. In multiple regression analyses, only
Hispanic race/ethnicity was associated with lower risk.
Age was the only variable associated with a higher inci-
dence of cerebrovascular disease.
Cumulative prevalence of cerebrovascular disease was
5.8%. Hispanic and Asian race/ethnicities were associated
with lower cumulative prevalences of cerebrovascular dis-
ease, as was year of diabetes diagnosis. Age at baseline and
Table 5: Risk factors for incident comorbid conditions
Hazard Ratio, (95% Confidence Interval)





Heart Disease 1.34 (1.19–1.50) 1.26 (1.06–1.50) 1.00 (0.84–1.20) 0.83 (0.62–1.13) 0.63 (0.42–0.95) 1.48 (1.42–1.54) 1.07 (1.03–1.12)
Congestive 
Heart Failure
1.57 (1.31–1.87) 1.10 (0.85–1.43) 0.57 (0.40–0.81) 0.55 (0.31–0.98) 0.99 (0.59–1.67) 1.56 (1.46–1.67) 1.06 (0.99–1.13)
Myocardial 
Infarction
1.71 (1.25–2.32) 1.81 (1.23–2.67) 0.95 (0.56–1.61) 0.47 (0.15–1.49) 0.45 (0.11–1.84) 1.56 (1.40–1.75) 1.01 (0.90–1.15)
Cerebrovascular 
Disease
1.20 (0.96–1.52) 1.08 (0.77–1.51) 0.61 (0.39–0.97) 0.47 (0.21–1.05) 0.56 (0.23–1.35) 1.66 (1.53–1.82) 0.99 (0.90–1.09)
Hypertension 1.04 (0.96–1.13) 0.71 (0.62–0.81) 0.67 (0.59–0.75) 0.78 (0.65–0.94) 0.61 (0.49–0.76) 1.32 (1.28–1.36) 1.29 (1.25–1.33)
Hazard ratios are adjusted for other variables shown in the table: sex, race/ethnicity, exact year of age, and year of diabetes incidence. Reference 
groups for hazard ratios are: Females (for Males); African Americans (for White, Hispanic, Asian, and Other); lower age; and earlier year of diabetes 
diagnosis.
Table 6: Associations with cumulative prevalence of comorbid conditions
Associations with Cumulative Prevalence of Comorbidities Odds Ratio, (95% Confidence Interval)





Heart Disease 1.33 (1.21–1.46) 1.32 (1.14–1.53) 0.78 (0.66–0.91) 0.58 (0.45–0.76) 0.52 (0.38–0.72) 1.71 (1.65–1.78) 0.85 (0.82–0.87)
Congestive 
Heart Failure
1.48 (1.28–1.71) 0.99 (0.79–1.23) 0.43 (0.31–0.58) 0.44 (0.28–0.70) 0.66 (0.41–1.05) 1.68 (1.59–1.78) 0.85 (0.82–0.88)
Myocardial 
Infarction
1.56 (1.22–2.00) 1.90 (1.39–2.59) 0.78 (0.50–1.23) 0.27 (0.09–0.85) 0.40 (0.13–1.26) 1.53 (1.39–1.67) 0.81 (0.75–0.87)
Cerebrovascular 
Disease
1.32 (1.11–1.57) 0.99 (0.76–1.29) 0.62 (0.44–0.86) 0.49 (0.28–0.86) 0.31 (0.13–0.70) 1.80 (1.69–1.93) 0.82 (0.78–0.86)
Hypertension 0.87 (0.79–0.97) 0.58 (0.49–0.68) 0.41 (0.36–0.48) 0.39 (0.30–0.49) 0.33 (0.25–0.43) 1.85 (1.78–1.93) 0.91 (0.88–0.93)
Odds ratios are adjusted for other variables shown in the table: sex, race/ethnicity, exact year of age, and year of diabetes incidence. Reference 
groups for hazard ratios are: Females (for Males); African Americans (for White, Hispanic, Asian, and Other); lower age; and earlier year of diabetes 
diagnosis.BMC Public Health 2005, 5:15 http://www.biomedcentral.com/1471-2458/5/15
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male sex were positively associated with cumulative prev-
alence of cerebrovascular disease.
Hypertension
A majority of patients (51.8%) had a diagnosis of hyper-
tension at baseline (Table 3). Non-Hispanic white, His-
panic, Asian, and "other" race/ethnicities were all
associated with lower baseline prevalence of hyperten-
sion, as was male sex (Table 4). Age and year of diabetes
diagnosis were associated with higher baseline
prevalence.
An additional 2,578 patients were diagnosed with hyper-
tension after diabetes diagnosis, for a cumulative preva-
lence of 7,804 (77.3%). The incidence rate was 26.46
cases per 100 person-years. Non-Hispanic white, His-
panic, Asian, and "other" race/ethnicities were all associ-
ated with lower incidence of hypertension than the
African-American reference group, while age and later
date of diabetes diagnosis were associated with higher
incidence.
Cumulative prevalence of hypertension was negatively
associated with non-Hispanic white, Hispanic, Asian, and
"other" race/ethnicities, male sex and year of diabetes
diagnosis, and positively associated with age.
Discussion
Patients in the Urban Diabetics Study cohort, like other
diabetic patient populations, faced a substantial burden
of cardiovascular comorbidity. Many were affected by
comorbid conditions before they were diagnosed with
diabetes, including 14.8% with preexisting heart disease,
2.9% with preexisting cerebrovascular disease, and 51.8%
with preexisting hypertension. Among those free of these
comorbidities at the time of diabetes diagnosis, similar
proportions went on to develop them during followup.
The diabetic patients served by the Philadelphia HCCs are
almost uniformly low-income and uninsured or underin-
sured. A large majority are African American. Nonetheless,
the prevalence and incidence of major cardiovascular
complications does not, in general, appear to exceed the
rates of these complications in other patient populations,
Table 2: Data sources for cardiovascular comorbid conditions
Outpatient 
only















Heart Disease 1125 700 38 731 9 31 59
Congestive 
Heart Failure
330 314 6 246 2 7 7
Myocardial 
Infarction
5 2 4 0 1 33090
Cerebrovascular 
Disease
109 333 9 123 0 11 3
Hypertension 5248 218 0 2296 9 3 30
Table 3: Baseline prevalence, incidence, and cumulative prevalence of cardiovascular comorbid conditions
Comorbidities Total Cases Cumulative 
Prevalence
Baseline Prevalence At or Before 
Initial Diabetes Diagnosis








Heart Disease 2,693 26.7% 1,495 14.8% 1,198 13.9% 5.36
Congestive 
Heart Failure
912 9.0% 417 4.1% 495 5.1% 1.85
Myocardial 
Infarction
270 2.7% 104 1.0% 166 1.7% 0.59
Cerebrovascular 
Disease
588 5.8% 294 2.9% 294 3.0% 1.07
Hypertension 7,804 77.3% 5,226 51.8% 2,578 52.9% 26.46BMC Public Health 2005, 5:15 http://www.biomedcentral.com/1471-2458/5/15
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whether assessed in nationally-representative surveys or
in insured, predominantly middle class managed care
populations. Disparities associated with race/ethnicity
were in varying directions. Non-Hispanic whites had
lower rates of hypertension than African Americans but
higher rates of heart disease, especially MI, while Asians
and Hispanics had more favorable outcomes on several
measures.
As expected, age was positively associated with all cardio-
vascular comorbidities. Male sex was associated with
higher incidence and prevalence of all comorbidities
except hypertension.
These findings are comparable to those for other diabetic
populations not limited to low-income or uninsured
patients. The cumulative prevalence of any heart disease
in this study population (26.7%) was similar to the 24.5%
prevalence of self-reported coronary heart disease among
diabetic patients in the nationally representative 1999–
2001 National Health Interview Surveys (NHIS), while
the cumulative prevalence of cerebrovascular disease in
our study (5.8%) was substantially lower than self-
reported stroke in the NHIS sample (9.3%) [3]. However,
the age distribution of diabetics in the NHIS sample was
substantially older than in this population. If the compar-
ison is restricted to NHIS diabetic patients age 35–64,
national prevalences were 31% lower than in our popula-
tion for heart disease (18.4% vs. 26.7%) and almost iden-
tical for cerebrovascular disease (5.9% vs. 5.8%). The
overall incidence rate of MI (0.59 per 100 person-years) in
the Urban Diabetics cohort was lower than that in the Kai-
ser Permanente managed care population studied by
Karter, et al. [4]. Again, this may reflect the fact that the
Urban Diabetics cohort was younger (mean age 49.2 years
vs. 59.8 years). When the overall incidence rate in our
population is multiplied by the hazard ratio for 10 years
additional age in our study, the result (0.92 per 100 per-
son-years) is almost identical to the age- and sex-adjusted
rate for African Americans reported by Karter, et al. (0.91
per 100 person-years). The incidence rate of CHF, on the
other hand, was higher in our population than in studies
of Kaiser Permanente patients [5], while that of cerebrov-
ascular disease was similar to the incidence of stroke
reported by Karter, et al. Another study conducted with
the Kaiser Permanente diabetes patients found evidence
of hypertension for 74% of those diagnosed with diabetes
[6], similar to the 77% cumulative prevalence in the
Urban Diabetics study.
Other studies have reported somewhat divergent findings
for heart disease [7,8] and cerebrovascular disease [9-11],
but these studies involved either younger type 1 diabetic
patients [7], earlier time periods [8], an older population
[9], or analyses that excluded some patients with prior his-
tories of cardiovascular disease [10,11]. Several studies
have reported high rates of hypertension among diabetic
patients, although none as high as the cumulative preva-
lence in this cohort [9,11-14].
Many of our findings on racial/ethnic differences in the
incidence of MI, CHF, and cerebrovascular disease among
diabetic patients are also similar to those found by Karter,
et al. Like them, we found higher risks of MI for non-His-
panic whites than for other groups, and lower risks of CHF
and cerebrovascular disease for Hispanics and Asians than
for African Americans and non-Hispanic whites. The mag-
nitudes of the differences between African-American and
Table 4: Associations with baseline prevalence of comorbid conditions
Odds Ratio, (95% Confidence Interval)





Heart Disease 1.24 (1.10–1.39) 1.32 (1.11–1.57) 0.59 (0.48–0.73) 0.45 (0.31–0.65) 0.49 (0.32–0.74) 1.73 (1.66–1.81) 1.02 (0.99–1.05)
Congestive 
Heart Failure
1.33 (1.08–1.63) 0.86 (0.63–1.19) 0.28 (0.17–0.48) 0.37 (0.18–0.75) 0.32 (0.13–0.79) 1.76 (1.63–1.89) 1.06 (1.00–1.12)
Myocardial 
Infarction
1.36 (0.92–2.01) 1.94 (1.19–3.14) 0.52 (0.23–1.21) 0.00 (0.00->9.99) 0.31 (0.04–2.26) 1.47 (1.28–1.70) 1.03 (0.92–1.15)
Cerebrovascular 
Disease
1.46 (1.15–1.85) 0.90 (0.61–1.32) 0.64 (0.41–1.00) 0.56 (0.27–1.14) 0.10 (0.01–0.70) 1.89 (1.73–2.06) 1.01 (0.94–1.08)
Hypertension 0.75 (0.69–0.82) 0.69 (0.60–0.79) 0.39 (0.34–0.45) 0.32 (0.26–0.41) 0.30 (0.23–0.40) 1.85 (1.78–1.91) 1.85 (1.78–1.91)
Odds ratios are adjusted for other variables shown in the table: sex, race/ethnicity, exact year of age, and year of diabetes incidence. Reference 
groups for odds ratios are: Females (for Males); African Americans (for White, Hispanic, Asian, and Other); lower age; and earlier year of diabetes 
diagnosis.BMC Public Health 2005, 5:15 http://www.biomedcentral.com/1471-2458/5/15
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non-Hispanic white rates were broadly similar between
the two studies, while rates for Asians and Hispanics were
more variable. The 1999–2001 NHIS also found the prev-
alence of coronary and other heart disease among patients
with diabetes (based on self-reported data) highest
among non-Hispanic whites and lowest among Hispanics
(rates for Asians were not reported) [3]. Unlike our study,
the NHIS analyses found rates of cerebrovascular disease
higher among African Americans with diabetes than
among either Hispanics or non-Hispanic whites. Among
diabetic patients in the Veterans Health Administration,
rates of cardiovascular disease were lower for African
Americans, Hispanics, and Asians than for non-Hispanic
whites [9]. However, that study was restricted to patients
with at least 4 outpatient clinic visits in a 12-month
period, and race/ethnicity was not ascertained for 21.4%
of the patients in that study, leaving considerable poten-
tial for bias in these results.
In our study, male sex was associated with higher baseline
prevalence of all comorbidities, higher incidence of the
heart disease comorbidities, and higher cumulative preva-
lence of all comorbidities except hypertension. Our find-
ings are broadly consistent with those in other diabetic
populations [3,4,15].
The similarities of our findings to those from the Kaiser
Permanente studies are striking, given that the latter
assessed an insured, West Coast cohort in which most His-
panics were Mexican American [4], while our study popu-
lation was an overwhelmingly poor, uninsured or
underinsured, East Coast cohort in which most Hispanics
were Puerto Rican. The national origins of the Asian
patients in the two studies probably also differ, as the
Philadelphia Asian community includes larger propor-
tions of South and Southeast Asians and smaller propor-
tions of Japanese and Filipino individuals than the Asian
communities of northern California [16]. Among both
Hispanics and Asian Americans, national groups vary
widely in socioeconomic status and health outcomes [17-
19].
Our study is based on administrative records from several
sources, each of which may contain errors, and is unlikely
to capture as many cardiovascular endpoints than studies
with study-specific, patient-level data collection [20,21].
Because the outpatient encounter forms allowed a maxi-
mum of four diagnostic codes, there may have been
underreporting of some comorbidities, although cardio-
vascular disease was unlikely to go unrecorded. Outpa-
tient care outside of the eight Philadelphia HCCs and
hospitalizations outside of Pennsylvania were not ascer-
tained. The design of the study could therefore under-
count comorbid conditions and cardiovascular endpoints
for patients who acquired health insurance or moved out
of the city and therefore changed outpatient providers. As
a test of the sensitivity of the results to migration in and
out of the health system, we repeated the analyses, restrict-
ing the follow-up time from the dates of the first to the last
to outpatient visit; the results were not materially
changed.
Among the strengths of the study are its inclusion of a
wide range of complications, 8+ year longitudinal design,
large sample size, and the combination of data sources to
enhance endpoint ascertainment. Our design captured
diabetes diagnoses and cardiovascular comorbidity and
endpoint data from three complementary sources: outpa-
tient visits in any of the eight Philadelphia HCCs, inpa-
tient visits within any hospital in Pennsylvania and death
certificate records. Table 2 supports the observation of
Kashner and colleagues that the addition of outpatient
administrative data resulted in significantly higher esti-
mates of comorbidity prevalence, strongly suggesting that
it has value as an additional data source [22].
By limiting the study to patients with an initial diabetes
diagnosis after the first 34 months for which we have data,
we were able to ascertain the prevalence of cardiovascular
conditions before and at the time of diabetes diagnosis as
well as incident conditions diagnosed after diabetes inci-
dence. We are unaware of any study that has presented
similar data except for one limited to elderly African
Americans and whites in North Carolina, which included
only 653 patients with diabetes [23]. The fact that patients
included in the study had no record of a diabetes diagno-
sis either in the Philadelphia Health Care Centers or in a
hospital discharge record between March 1993 and the
date of their diabetes diagnosis, which was no earlier than
January 1996, should ensure that the great majority of
patients included here were incident diabetes cases.
There is a strong, well-established association between
socioeconomic disadvantage and cardiovascular disease
in industrialized populations [24], including diabetic
populations [25]. The absence of excess cardiovascular
disease beyond that experienced in other diabetic patient
populations in this disadvantaged cohort suggests that
some factor has offset this disadvantage for this cohort.
One possibility is that the provision of primary care, other
outpatient services to which patients are referred by their
primary care physicians, and prescription medications
without out-of-pocket costs to all patients in the Philadel-
phia HCCs removes a significant barrier to effective care.
Restricted use of medications due to costs is common [26]
and has been shown to lead to poorer outcomes for sev-
eral chronic diseases, including cardiovascular diseases
[27,28].BMC Public Health 2005, 5:15 http://www.biomedcentral.com/1471-2458/5/15
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This is the only study of which we are aware to report on
cardiovascular comorbidity in a large, ethnically diverse
cohort of low-income patients with diabetes with near-
universal ascertainment of race/ethnicity. It includes sub-
stantial populations of low-income Asians, Hispanics,
and non-Hispanic whites as well as African Americans,
and allows comparisons of the experiences of these
groups. The data is longitudinal and includes both outpa-
tient and hospital discharges over an extended period. By
looking at comorbid conditions both before and after dia-
betes incidence, we have provided both a picture of the
health status of these patients at the initial presentation of
diabetes and estimates of the incidence of additional
comorbidities while being treated for diabetes.
Conclusions
Cardiovascular comorbidities were common both before
and after diabetes diagnosis in this low-income cohort,
but not substantially different from mixed-income man-
aged care populations. It is possible that access to primary
care and pharmacy services without fees to individuals in
this public health clinic system prevented the poorer out-
comes usually seen for disadvantaged patients.
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
JMR and DAW conceived the study and obtained the data.
JMR designed the study, performed the analyses, and
drafted the manuscript. DAW and CNS revised the manu-
script. All authors read and approved the final
manuscript.
Acknowledgements
This research was supported by grant #R21DK064201-01 from the 
National Institute of Diabetes, Digestive and Kidney Diseases.
References
1. Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg
EW, Tierney EF, Rios-Burrows N, Mokdad AH, Ford ES, Imperatore
G, Narayan V: The evolving diabetes burden in the United
States. Ann Intern Med 2004, 140:945-950.
2. Goldberg RB: Cardiovascular disease in patients who have
diabetes. Cardiology Clinics 2003, 21:399-413.
3. Centers for Disease Control and Prevention: Self-reported heart
disease and stroke among adults with and without diabetes
– United States, 1999–2001. MMWR Morbidity & Mortality Weekly
Report 2003, 52:1065-70.
4. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV: Eth-
nic disparities in diabetic complications in an insured
population. JAMA 2002, 287:2519-2527.
5. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV:
Glycemic control and heart failure among adult patients
with diabetes. Circulation 2001, 103:2668-2673.
6. Selby JV, Peng T, Karter AJ, Alexander M, Sidney S, Lian J, Arnold A,
Pettitt D: High rates of co-occurrence of hypertension, ele-
vated low-density lipoprotein cholesterol, and diabetes mel-
litus in a large managed care population. Am J Manag Care 2004,
10:163-170.
7. Zgibor JC, Songer TJ, Kelsey SF, Drash AL, Orchard TJ: Influence of
health care providers on the development of diabetes com-
plications: long-term follow-up from the Pittsburgh Epide-
miology of Diabetes Complications Study. Diabetes Care 2002,
25:1584-1590.
8. Wingard DL, Barrett-Connor E: Heart disease and diabetes. In
Diabetes in America 2nd edition. Edited by: National Diabetes Data
Group. Washington, DC: US Govt Printing Office (NIH publ no 95-
1468); 1995:429-448. 
9. Young BA, Maynard C, Boyko EJ: Racial differences in diabetic
nephropathy, cardiovascular disease, and mortality in a
national population of veterans.  Diabetes Care 2003,
26(8):2392-2399.
10. Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil A, Hol-
man RR: Risk of stroke in type 2 diabetes estimated by the UK
Prospective Diabetes Study risk engine.  Stroke 2002,
33:1776-1781.
11. Lee CD, Folsom AR, Pankow JS, Brancati FL: Cardiovascular
events in diabetic and nondiabetic adults with or without his-
tory of myocardial infarction. Circulation 2004, 109:855-860.
12. Baumann LC, Chang MW, Hoebeke R: Clinical outcomes for low-
income adults with hypertension and diabetes.  Nursing
Research 2002, 51:191-198.
13. Spijkerman AMW, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer
CDA, Bouter LM, Heine RJ: Diabetic patients detected by pop-
ulation-based stepwise screening already have a diabetic car-
diovascular risk profile. Diabetes Care 2002, 25:1784-1789.
14. Klein BEK, Klein R, Lee KE: Components of the metabolic syn-
drome and risk of cardiovascular disease and diabetes in
Beaver Dam. Diabetes Care 2002, 25:1790-1794.
15. Barzilay JI, Spiekerman CF, Kuller LH, Burke GL, Bittner V, Gottdi-
ener JS, Brancati FL, Orchard TJ, O'Leary DH, Savage PJ: Prevalence
of clinical and isolated subclinical cardiovascular disease in
older adults with glucose disorders: the Cardiovascular
Health Study. Diabetes Care 2001, 24:1233-1239.
16. Census 2000 Summary File 3  [http://www.census.gov]
17. Arias E, Anderson RN, Hsiang-Ching K, Murphy SL, Kochanek KD:
Deaths:Final data for 2001. Natl Vital Stat Rep 2003, 52(3):1-115.
18. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA,
Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M: Dif-
ferences in risk factors, atherosclerosis and cardiovascular
disease between ethnic groups in Canada: the study of health
assessment and risk in ethnic groups (SHARE). Indian Heart J
2000, 52(Suppl 7):S35-43.
19. Klatsky A: The risk of hospitalization for ischemic heart dis-
ease among Asian Americans in Northern California. Am J
Public Health 1994, 84:1672-1675.
20. Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Heiss
G, Sharrett AR: Lipoprotein-associated phospholipase A2,
high-sensitivity C-reactive protein, and risk for incident cor-
onary heart disease in middle-aged men and women in the
Atherosclerosis Risk in Communities (ARIC) study. Circulation
2004, 109:837-842.
21. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P,
Brown C, Roccella EJ: Trends in the prevalence, awareness,
treatment, and control of hypertension in the adult US pop-
ulation. Data from the health examination surveys, 1960 to
1991. Hypertension 1995, 26:60-69.
22. Kashner TM: Agreement between administrative files and
written medical records: a case of the Department of Veter-
ans Affairs. Med Care 1998, 36:1324-1336.
23. Fillenbaum GG, Pieper CF, Cohen HD, Cornoni-Huntley JC, Guralnik
J: Comorbidity of five chronic health conditions in elderly
community residents: determinants and impact on
mortality. J Gerontol A Biol Sci Med Sci 2000, 55(2):M84-M89.
24. Kaplan GA, Keil JE: Socioeconomic factors and cardiovascular
disease: a review of the literature. Circulation 1993, 88(4 Pt
1):1973-1998.
25. Bachmann MO, Eachus J, Hopper CD, Davey Smith G, Propper C,
Pearson NJ, Williams S, Tallon D, Frankel S: Socio-economic ine-
qualities in diabetes complications, control, attitudes and
health service use: a cross-sectional study. Diabet Med 2003,
20:921-929.
26. Artz MB, Hadsall RS, Schondelmeyer SW: Impact of generosity
level of outpatient prescription drug coverage on prescrip-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Public Health 2005, 5:15 http://www.biomedcentral.com/1471-2458/5/15
Page 9 of 9
(page number not for citation purposes)
tion drug events and expenditure among older persons. Am J
Public Health 2002, 92:1257-1263.
27. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N,
Hurley J, Grad R, Latimer E, Perreault R, McLeod P, Huang A, Laro-
chelle P, Mallet L: Adverse events associated with prescription
drug cost-sharing among poor and elderly persons.  JAMA
2001, 285:421-429.
28. Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD:
The health effects of restricting prescription medication use
because of cost. Med Care 2004, 42:626-34.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/5/15/prepub